{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:45:19Z","timestamp":1759063519604},"reference-count":64,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/ol.2016.5393","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T13:11:57Z","timestamp":1479388317000},"page":"307-314","source":"Crossref","is-referenced-by-count":13,"title":["Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases"],"prefix":"10.3892","volume":"13","author":[{"given":"Yong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"key":"key20180108113625_b1-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/14656566.2012.649727","article-title":"Adefovir dipivoxil in chronic hepatitis B: history and current uses","volume":"13","author":"Segovia","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"iii-iv","key":"key20180108113625_b2-ol-0-0-5393","first-page":"xi","article-title":"Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: A systematic review and economic evaluation","volume":"10","author":"Shepherd","year":"2006","journal-title":"Health Technol Assess"},{"key":"key20180108113625_b3-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/187152609787847677","article-title":"Drug targets in hepatitis B virus infection","volume":"9","author":"Stein","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"key20180108113625_b4-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/j.ijid.2011.11.006","article-title":"Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B","volume":"16","author":"Chen","year":"2012","journal-title":"Int J Infect Dis"},{"key":"key20180108113625_b5-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2165\/00003495-200666140-00005","article-title":"Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B","volume":"66","author":"Han","year":"2006","journal-title":"Drugs"},{"key":"key20180108113625_b6-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0b013e3181e12ed3","article-title":"Hypophosphataemic osteomalacia in patients on adefovir dipivoxil","volume":"45","author":"Girgis","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"key20180108113625_b7-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2710.2011.01278.x","article-title":"Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil-is there a safe dose?","volume":"37","author":"Law","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"key20180108113625_b8-ol-0-0-5393","first-page":"1956","article-title":"Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B","volume":"31","author":"Li","year":"2011","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180108113625_b9-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12288-015-0501-x","article-title":"Misdiagnosis of Bone Metastasis Cancer After Using Adefovir Dipivoxi in a Hepatitis B Patient with Fanconi Syndrome","volume":"32","author":"Li","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"key20180108113625_b10-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4055\/cios.2016.8.2.232","article-title":"Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B","volume":"8","author":"Lee","year":"2016","journal-title":"Clin Orthop Surg"},{"key":"key20180108113625_b11-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.ajkd.2010.03.026","article-title":"Comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels above 60 ml\/min\/1.73 m2","volume":"56","author":"Stevens","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key20180108113625_b12-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"key20180108113625_b13-ol-0-0-5393","first-page":"730","article-title":"Dissection of mechanism for the adefovir dipivoxil resistance in chronic hepatitis B patients","volume":"17","author":"Zeng","year":"2009","journal-title":"Zhonghua ganzangbing zazhi"},{"key":"key20180108113625_b14-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: A randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"JAMA"},{"key":"key20180108113625_b15-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"key20180108113625_b16-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B","volume":"49","author":"Fontana","year":"2009","journal-title":"Hepatology"},{"key":"key20180108113625_b17-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14310\/horm.2002.11156","article-title":"Hypophosphataemic osteomalacia due to de Toni-Debre-Fanconi syndrome in a 19-year old girl","volume":"4","author":"Tsilchorozidou","year":"2005","journal-title":"Hormones"},{"key":"key20180108113625_b18-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1345\/aph.1M120","article-title":"Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab","volume":"43","author":"Shaikh","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key20180108113625_b19-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000166782","article-title":"The various renal manifestations of the nephropathic form of cystinosis","volume":"4","author":"Lemire","year":"1984","journal-title":"Am J Nephrol"},{"key":"key20180108113625_b20-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0022-3476(65)80190-1","article-title":"Acquired Fanconi Syndrome Following Degraded Tetracycline","volume":"66","author":"Cleveland","year":"1965","journal-title":"J Pediatr"},{"key":"key20180108113625_b21-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/1097-0142(197802)41:2<769::AID-CNCR2820410251>3.0.CO;2-C","article-title":"Fanconi syndrome associated with cephalothin and gentamicin therapy","volume":"41","author":"Schwartz","year":"1978","journal-title":"Cancer"},{"key":"key20180108113625_b22-ol-0-0-5393","first-page":"594","article-title":"Ifosfamide-induced nephrotoxicity","volume":"141","author":"Rossi","year":"1993","journal-title":"Monatsschr Kinderheilkd"},{"key":"key20180108113625_b23-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.0013-9580.2004.05504.x","article-title":"Fanconi syndrome caused by antiepileptic therapy with valproic Acid","volume":"45","author":"Knorr","year":"2004","journal-title":"Epilepsia"},{"key":"key20180108113625_b24-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0971-4065.127898","article-title":"Tenofovir induced Fanconi syndrome: A rare cause of hypokalemic paralysis","volume":"24","author":"Venkatesan","year":"2014","journal-title":"Indian J Nephrol"},{"key":"key20180108113625_b25-ol-0-0-5393","first-page":"309","article-title":"Fanconi syndrome caused by low-dose adefovir dipivoxil","volume":"35","author":"Zhu","year":"2014","journal-title":"Saudi Med J"},{"key":"key20180108113625_b26-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2169\/internalmedicine.50.4855","article-title":"A case of acquired Fanconi syndrome induced by zoledronic acid","volume":"50","author":"Yoshinami","year":"2011","journal-title":"Intern Med"},{"key":"key20180108113625_b27-ol-0-0-5393","first-page":"735","article-title":"The clinical and biochemical manifestations of Fanconi syndrome: A report of 42 cases","volume":"39","author":"Zheng","year":"2000","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"key20180108113625_b28-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/ndt\/gfm189","article-title":"Tubulo-interstitial nephritis with Fanconi syndrome in Behcet disease","volume":"22","author":"Belmouaz","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108113625_b29-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1053\/j.ajkd.2006.08.009","article-title":"Aminoglycoside-associated Fanconi syndrome","volume":"48","author":"Ghiculescu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key20180108113625_b30-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/apc.2007.0052","article-title":"Tenofovir-associated Fanconi syndrome: Review of the FDA adverse event reporting system","volume":"22","author":"Gupta","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"key20180108113625_b31-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/dkm143","article-title":"Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir","volume":"60","author":"Kazory","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key20180108113625_b32-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ajkd.2007.10.039","article-title":"Partial fanconi syndrome induced by imatinib therapy: A novel cause of urinary phosphate loss","volume":"51","author":"Francois","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"A57","key":"key20180108113625_b33-ol-0-0-5393","first-page":"e43","article-title":"Light chain-associated Fanconi syndrome with nephrotic-range proteinuria","volume":"47","author":"Aslam","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key20180108113625_b34-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5414\/CNP67255","article-title":"Adult-onset acute tubulointerstitial nephritis and uveitis with Fanconi syndrome. Case report and review of the literature","volume":"67","author":"Koike","year":"2007","journal-title":"Clin Nephrol"},{"key":"key20180108113625_b35-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1093\/ndt\/gfm467","article-title":"Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: A case report and literature review","volume":"22","author":"D'Ythurbide","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108113625_b36-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"key20180108113625_b37-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol Pharmacol"},{"key":"key20180108113625_b38-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"key20180108113625_b39-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3748\/wjg.v21.i7.2116","article-title":"Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B","volume":"21","author":"Shimizu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20180108113625_b40-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0091270005278949","article-title":"Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration","volume":"45","author":"Kearney","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"key20180108113625_b41-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5009\/gnl.2010.4.3.389","article-title":"Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient","volume":"4","author":"Jung","year":"2010","journal-title":"Gut Liver"},{"key":"key20180108113625_b42-ol-0-0-5393","first-page":"590","article-title":"Adefovir dipivoxil effects on and related factors of blood phosphorus metabolism in patients with chronic hepatitis B","volume":"23","author":"Ning","year":"2015","journal-title":"Zhonghua ganzangbing zazhi"},{"key":"key20180108113625_b43-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.23044","article-title":"Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil","volume":"50","author":"Ha","year":"2009","journal-title":"Hepatology"},{"key":"key20180108113625_b44-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: Haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"key20180108113625_b45-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5604\/16652681.1171746","article-title":"The treatment of diabetes mellitus of patients with chronic liver disease","volume":"14","author":"Garc\u00eda-Compe\u00e1n","year":"2015","journal-title":"Ann Hepatol"},{"key":"key20180108113625_b46-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of Patients with Cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N Engl J Med"},{"key":"key20180108113625_b47-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"key20180108113625_b48-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-014-1712-z","article-title":"Tenofovir-induced nephrotoxicity: Incidence, mechanism, risk factors, prognosis and proposed agents for prevention","volume":"70","author":"Jafari","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"key20180108113625_b49-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjmed.2015.08.025","article-title":"National Kidney Foundation Kidney Disease Outcomes Quality Initiative: Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician","volume":"129","author":"Vassalotti","year":"2016","journal-title":"Am J Med"},{"key":"key20180108113625_b50-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15171\/jrip.2016.33","article-title":"Correlation between cystatin C-based formulas, Schwartz formula and urinary creatinine clearance for glomerular filtration rate estimation in children with kidney disease","volume":"5","author":"Safaei-Asl","year":"2016","journal-title":"J Renal Inj Prev"},{"key":"key20180108113625_b51-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function-measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108113625_b52-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2007.11.009","article-title":"Prevalence and factors associated with CKD: A population study from Beijing","volume":"51","author":"Zhang","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key20180108113625_b53-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"Weiner","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key20180108113625_b54-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: A cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"key20180108113625_b55-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/ndt\/gfn767","article-title":"Community-based study on CKD subjects and the associated risk factors","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108113625_b56-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3748\/wjg.v12.i11.1752","article-title":"Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells","volume":"12","author":"Deng","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180108113625_b57-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7869\/tg.295","article-title":"Renal disease in patients infected with hepatitis B virus","volume":"36","author":"Jaryal","year":"2015","journal-title":"Trop Gastroenterol"},{"key":"key20180108113625_b58-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/liv.12480","article-title":"Prevalence of renal abnormalities in chronic HBV infection: The HARPE study","volume":"35","author":"Amet","year":"2015","journal-title":"Liver Int"},{"key":"key20180108113625_b59-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/MEG.0000000000000173","article-title":"Frequency, pattern and short-term outcome of chronic renal dysfunction in patients with cirrhosis: A prospective study using HRS and ADQI-IAC criteria","volume":"26","author":"De Silva","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180108113625_b60-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2010.01.009","article-title":"Serum sodium, renal function, and survival of patients with end-stage liver disease","volume":"52","author":"Lim","year":"2010","journal-title":"J Hepatol"},{"key":"key20180108113625_b61-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1440-1746.2008.05510.x","article-title":"Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites","volume":"23","author":"Kim","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108113625_b62-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1478-3231.2011.02641.x","article-title":"Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B","volume":"32","author":"Minde","year":"2012","journal-title":"Liver Int"},{"key":"key20180108113625_b63-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0971-4065.144423","article-title":"Adefovir nephrotoxicity in a renal allograft recipient","volume":"25","author":"George","year":"2015","journal-title":"Indian J Nephrol"},{"key":"key20180108113625_b64-ol-0-0-5393","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J Am Soc Nephrol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.5393\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:49:38Z","timestamp":1657759778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.5393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,17]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/ol.2016.5393"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.5393","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}